Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PODD

Insulet Corp

May 12 • 04:00PM ET

158.35

+4.18 2.71 %

Healthcare • Medical Devices • USA • Large • NASD

Peers: TNDM DXCM MDT ABT ICUI BDX MASI ITGR CNMD STE

| Held by: VTI VOO VB VO IVV SPY VUG RSP VBK XLV

Scroll to Statements

Index	S&P 500	P/E	36.86	EPS (ttm)	4.30	Insider Own	0.41%	Shs Outstand	69.26M	Perf Week	-5.48%
Market Cap	10.97B	Forward P/E	19.45	EPS next Y	8.14	Insider Trans	1.95%	Shs Float	68.98M	Perf Month	-19.95%
Enterprise Value	11.44B	PEG	0.71	EPS next Q	1.46	Inst Own	103.97%	Short Float	4.30%	Perf Quarter	-37.26%
Income	302.80M	P/S	3.78	EPS this Y	30.33%	Inst Trans	-0.07%	Short Ratio	2.49	Perf Half Y	-50.49%
Sales	2.90B	P/B	8.42	EPS next Y	25.72%	ROA	9.31%	Short Interest	2.97M	Perf YTD	-44.29%
Book/sh	18.81	P/C	22.83	EPS next 5Y	27.32%	ROE	23.00%	52W High	354.88 -55.38%	Perf Year	-50.00%
Cash/sh	6.94	P/FCF	26.38	EPS past 3/5Y	275.33% 102.14%	ROIC	13.57%	52W Low	148.30 6.77%	Perf 3Y	-52.05%
Dividend Est.	-	EV/EBITDA	18.28	Sales past 3/5Y	27.54% 24.53%	Gross Margin	71.64%	Volatility	6.49% 4.47%	Perf 5Y	-29.78%
Dividend TTM	-	EV/Sales	3.94	EPS Y/Y TTM	-24.86%	Oper. Margin	17.47%	ATR (14)	8.23	Perf 10Y	479.82%
Dividend Ex-Date	-	Quick Ratio	1.78	Sales Y/Y TTM	31.93%	Profit Margin	10.44%	RSI (14)	32.89	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	2.45	EPS Q/Q	158.51%	SMA20	-11.34%	Beta	1.18	Target Price	248.50
Payout	0.00%	Debt/Eq	0.73	Sales Q/Q	33.87%	SMA50	-22.21%	Rel Volume	1.13	Prev Close	154.17
Employees	5400	LT Debt/Eq	0.71	Earnings	May 06 BMO	SMA200	-42.97%	Avg Volume	1.19M	Price	158.35
IPO	May 15, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	18.46% 4.36%	Trades		Volume	1,341,301	Change	2.71%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-24-26	Downgrade	Rothschild & Co Redburn	Buy → Neutral	$220
Apr-07-26	Downgrade	Citigroup	Buy → Neutral	$230
Jan-27-26	Resumed	TD Cowen	Hold	$294
Jan-12-26	Downgrade	Barclays	Overweight → Equal Weight	$274
Dec-16-25	Initiated	Evercore ISI	Outperform	$370
Nov-19-25	Upgrade	UBS	Neutral → Buy	$400
Oct-21-25	Resumed	Stifel	Buy	$370
Sep-08-25	Resumed	Oppenheimer	Outperform	$365
Jun-16-25	Initiated	Truist	Buy	$365
May-30-25	Initiated	Goldman	Buy	$380
May-13-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$350
Apr-29-25	Downgrade	Wolfe Research	Outperform → Peer Perform
Mar-06-25	Initiated	RBC Capital Mkts	Outperform	$340
Nov-06-24	Initiated	Bernstein	Outperform	$300
May-30-24	Initiated	Redburn Atlantic	Buy	$235
May-07-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$200
Dec-21-23	Upgrade	Robert W. Baird	Neutral → Outperform	$180 → $238
Dec-04-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$185 → $234
Oct-02-23	Upgrade	Jefferies	Hold → Buy	$260 → $240
Aug-21-23	Upgrade	Citigroup	Neutral → Buy	$273 → $265

Show Previous Ratings

May-12-26 09:56AM	Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls (The Fly)
May-06-26 01:00PM	Insulet Corporation Q1 2026 Earnings Call Summary (Moby) -9.70%
07:33AM	Insulet raises revenue expectations for 2026 (MedTech Dive)
07:16AM	Insulet: Q1 Earnings Snapshot (Associated Press)
07:00AM	Insulet Reports First Quarter 2026 Results (Business Wire)
07:00AM	Loading…
May-05-26 07:00AM	Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities (Business Wire)
May-04-26 07:00AM	Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes (Business Wire)
Apr-28-26 07:00AM	Insulet to Participate in BofA Securities 2026 Health Care Conference (Business Wire)
Apr-24-26 09:44AM	Intel upgraded, DraftKings downgraded: Wall Street's top analyst calls (The Fly)
Apr-23-26 11:54AM	Why BSX Stock's Q1 Beat Is A Lagging Indicator (Trefis)
Apr-01-26 07:00AM	Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026 (Business Wire)
Mar-31-26 03:09PM	MiniMed initiated with Buy rating by Bank of America on pipeline-driven growth outlook (Proactive)
06:30AM	Can Boston Scientific Stock Surge 40% From Here? (Trefis)
Mar-13-26 04:45PM	Iran War Drags Stocks Lower (Barchart) -6.88%
01:08PM	Insulet initiates Omnipod 5 recall following 18 AE reports (Medical Device Network)
11:18AM	Loading…
11:18AM	Stocks Erase Early Gains on Iran War Anxiety (Barchart)
07:31AM	Insulet reports 18 serious adverse events with recall of Omnipod 5 insulin pumps (MedTech Dive)
Mar-12-26 04:05PM	Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod 5 Pods in the U.S. (Business Wire)
Mar-11-26 04:01PM	Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes (Business Wire)
05:26AM	Insulet price target lowered to $338 from $345 at Citi (TipRanks)
Mar-10-26 07:00AM	Insulet to Present EVOLUTION 2 Results on Omnipod Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) (Business Wire)
Mar-03-26 09:10AM	Medtronic Debuts MiniMed Go Smart MDI With Simplera Sensor in Europe (Zacks)
Feb-26-26 10:29PM	Truist Lowers its Price Target on Insulet Corporation (PODD) to $360 and Maintains a Buy Rating (Insider Monkey)
Feb-24-26 11:33AM	AdvaMed names Jake Leach as chair of diabetes sector (MedTech Dive)
06:25AM	Medtronics MiniMed prices IPO at up to $784M (MedTech Dive)
Feb-23-26 03:46PM	O5 Adoption Leads to Bullish Views Around Insulet Corporation (PODD) (Insider Monkey)
Feb-20-26 05:00AM	Senseonics launches automated insulin dosing system with 1-year CGM (MedTech Dive)
Feb-19-26 08:09AM	PODD Stock Up on Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
12:31AM	PODD Q4 Deep Dive: Type 2 Diabetes Expansion and Innovation Drive Outperformance (StockStory)
Feb-18-26 04:33PM	Stocks Settle Higher on Signs of US Economic Strength (Barchart)
02:00PM	Loading…
02:00PM	Insulet Corp (PODD) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
01:57PM	Diabetes-Focused Insulet Forecasts Strong 2026 Growth, Stock Soars (Benzinga)
12:26PM	Insulet (PODD) Shares Skyrocket, What You Need To Know (StockStory)
11:40AM	Analyst Report: Insulet Corporation (Morningstar Research)
09:36AM	Insulet Q4 Earnings Call Highlights (MarketBeat)
09:30AM	Insulet (PODD) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
08:15AM	Insulet (PODD) Tops Q4 Earnings and Revenue Estimates (Zacks)
07:37AM	Insulet beats revenue expectations in fourth quarter, shares rise (Investing.com)
07:27AM	Insulet: Q4 Earnings Snapshot (Associated Press Finance)
07:07AM	Insulet (NASDAQ:PODD) Surprises With Q4 CY2025 Sales (StockStory)
07:00AM	Insulet Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
Feb-17-26 05:35PM	AtriCure (ATRC) Tops Q4 Earnings and Revenue Estimates (Zacks)
Feb-16-26 10:04PM	Earnings To Watch: Insulet (PODD) Reports Q4 Results Tomorrow (StockStory)
Feb-15-26 06:53AM	Insulet Corporation (PODD) Announces Strategic Expansion and Supply Agreement Update (Insider Monkey)
Feb-13-26 04:36PM	Analyst Report: DexCom, Inc. (Morningstar Research)
11:26AM	Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market (PR Newswire)
Feb-12-26 09:15AM	Exploring Analyst Estimates for Insulet (PODD) Q4 Earnings, Beyond Revenue and EPS (Zacks)
Feb-11-26 10:00AM	Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Feb-10-26 07:40AM	Zimmer Biomet (ZBH) Q4 Earnings and Revenues Top Estimates (Zacks)
Feb-05-26 07:00AM	Insulet Launches Omnipod 5 and Omnipod Discover in the Middle East to Transform Diabetes Care (Business Wire)
Feb-02-26 07:50PM	Insulet Corporation (PODD): A Bull Case Theory (Insider Monkey)
Jan-30-26 02:31PM	Reasons Why Hedge Funds Favor Insulet Corp (PODD) (Insider Monkey)
Jan-29-26 09:08PM	Analyst Report: Insulet Corporation (Morningstar Research)
Jan-27-26 09:37AM	Target upgraded, Stryker downgraded: Wall Street's top analyst calls (The Fly)
08:00AM	Here Are Tuesdays Top Wall Street Analyst Research Calls: Affirm Holdings, Alcoa, Block, Coinbase Global,CoreWeave, Datadog, Intuitive Surgical, and More (24/7 Wall St.)
Jan-26-26 09:45AM	Here's Why Insulet (PODD) is a Strong Growth Stock (Zacks)
Jan-23-26 07:30PM	Analyst Report: DexCom, Inc. (Morningstar Research)
Jan-22-26 08:59PM	Analyst Report: DexCom, Inc. (Morningstar Research)
08:24AM	What You Need To Know Ahead of Insulets Earnings Release (Barchart)
Jan-21-26 05:00AM	BVI appoints Jim Hollingshead as CEO (MedTech Dive)
Jan-20-26 07:20PM	Is Insulet (PODD) the Future of Diabetes Management? (Motley Fool)
Jan-15-26 05:26AM	JPM26: Insulet presents optimistic growth plan heading into 2026 (Medical Device Network)
Jan-14-26 12:53PM	Bernstein Reduces Firm's PT on Insulet (PODD) Stock (Insider Monkey)
Jan-12-26 09:49AM	Netflix initiated, Palantir upgraded: Wall Street's top analyst calls (The Fly)
Jan-09-26 09:45AM	Here's Why Insulet (PODD) is a Strong Growth Stock (Zacks)
06:00AM	Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 (Business Wire)
Jan-08-26 09:33AM	What Provides InsuletCorp. (PODD) With a Durable Competitive Advantage? (Insider Monkey)
Jan-06-26 07:00AM	Insulet Redefines Diabetes at CES with "Liveable Technology" - A New Frontier in Human-Centered Connected Health (Business Wire)
Jan-02-26 07:35AM	Is This the Right Time to Add PBH Stock to Your Portfolio? (Zacks)
07:34AM	Is it the Right Time to Add Insulet Stock to Your Portfolio? (Zacks)
Dec-31-25 04:54AM	Best Growth Stocks to Buy for December 31st (Zacks)
Dec-30-25 08:06AM	Should Myriad Genetics Stock Stay in Your Portfolio Right Now? (Zacks)
07:33AM	Reasons to Add Cooper Companies Stock to Your Portfolio Now (Zacks)
07:32AM	Should You Continue to Hold EXAS Stock in Your Portfolio Now? (Zacks)
Dec-29-25 08:52AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio Now (Zacks)
Dec-26-25 12:45PM	3 Reasons Growth Investors Will Love Insulet (PODD) (Zacks)
07:49AM	Should You Continue to Hold BRKR Stock in Your Portfolio? (Zacks)
07:18AM	Reasons to Retain Baxter International Stock in Your Portfolio Now (Zacks)
07:17AM	Reasons to Retain Penumbra Stock in Your Portfolio for Now (Zacks)
Dec-24-25 08:36AM	Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now? (Zacks)
Dec-23-25 02:08PM	Is This the Right Time to Add Veracyte Stock to Your Portfolio? (Zacks)
02:08PM	Abbott Stock May Benefit Following Volt PFA's FDA Approval (Zacks)
Dec-22-25 09:45AM	Why Insulet (PODD) is a Top Growth Stock for the Long-Term (Zacks)
08:42AM	Truist Cuts Insulet (PODD) PT but Maintains Buy as Top MedTech Pick for 2026 (Insider Monkey)
07:49AM	TMO Stock May Benefit From PPD CorEvitas Alzheimer's Registry Launch (Zacks)
01:50AM	Medtronics diabetes spinoff MiniMed files for IPO (MedTech Dive)
Dec-19-25 09:09AM	National Vision Stock Surges 154.6% in a Year: What's Driving it? (Zacks)
Dec-18-25 08:36AM	Should You Continue to Hold CRL Stock in Your Portfolio for Now? (Zacks)
07:45AM	Should Investors Hold Chemed Stock in Their Portfolio Now? (Zacks)
Dec-17-25 07:55AM	Should You Retain Teleflex Stock in Your Portfolio Now? (Zacks)
Dec-16-25 10:32AM	Is Insulet Stock Underperforming the Nasdaq? (Barchart)
07:58AM	Is Phibro Animal Health Stock a Smart Addition to Your Portfolio Now? (Zacks)
07:47AM	TMO Stock Set to Gain From the Expansion of Gibco Bacto Portfolio (Zacks)
07:00AM	Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-15-25 07:54AM	4 Medical Device Stocks to Buy for Healthy Returns in 2026 (Zacks)
07:00AM	Insulet Expands Omnipod U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future (Business Wire)
Dec-11-25 08:09AM	Should You Continue to Hold EW Stock in Your Portfolio? (Zacks)
Dec-10-25 12:45PM	Here is Why Growth Investors Should Buy Insulet (PODD) Now (Zacks)
Dec-08-25 10:34PM	Patient Monitoring Stocks Q3 In Review: Insulet (NASDAQ:PODD) Vs Peers (StockStory)
07:56AM	PODD Stock Benefits From FDA Approval of Omnipod 5's Enhancements (Zacks)

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MINOGUE MICHAEL R	Director	Feb 25 '26	Buy	246.23	2,030	499,847	17,483	Feb 26 07:05 AM
McEvoy Ashley	President and CEO	Feb 20 '26	Buy	239.35	4,300	1,029,205	13,916	Feb 23 08:14 AM
Frederick Wayne A.I.	Director	Dec 15 '25	Sale	293.09	1,851	542,510	2,158	Dec 16 04:04 PM
Frederick Wayne A.I.	Director	Dec 15 '25	Proposed Sale	293.09	1,851	542,500		Dec 15 03:03 PM
STONESIFER TIMOTHY C.	Director	Dec 05 '25	Buy	311.73	962	299,884	4,591	Dec 08 04:02 PM
Manea Dan	Former Officer	Nov 26 '25	Proposed Sale	326.64	4,475	1,461,716		Nov 26 04:31 PM
Manea Dan	Former Officer	Nov 24 '25	Proposed Sale	340.95	2,306	786,228		Nov 24 04:06 PM
Manea Dan	Former Officer	Sep 16 '25	Proposed Sale	337.73	1,347	454,920		Sep 16 01:21 PM
Singh Prem	SVP, Global Operations	Sep 08 '25	Sale	347.49	687	238,726	3,456	Sep 09 04:19 PM
Cousin Laetitia	SVP, Reg, Quality & Compliance	Sep 08 '25	Option Exercise	241.10	797	192,160	4,687	Sep 09 04:16 PM
Cousin Laetitia	SVP, Reg, Quality & Compliance	Sep 08 '25	Sale	348.81	797	278,002	3,890	Sep 09 04:16 PM
Cousin Laetitia	Officer	Sep 08 '25	Proposed Sale	348.81	797	278,000		Sep 08 02:07 PM
Singh Prem	Officer	Sep 08 '25	Proposed Sale	347.48	687	238,718		Sep 08 01:31 PM
Benjamin Eric	EVP, CPXO	Aug 21 '25	Sale	332.23	4,263	1,416,296	16,736	Aug 22 04:16 PM
Benjamin Eric	Officer	Aug 21 '25	Proposed Sale	332.23	4,263	1,416,296		Aug 21 10:21 AM
Singh Prem	SVP, Global Operations	Aug 07 '25	Option Exercise	271.28	1,343	364,325	5,486	Aug 08 04:03 PM
Singh Prem	SVP, Global Operations	Aug 07 '25	Sale	320.00	1,343	429,760	4,143	Aug 08 04:03 PM
Singh Prem	Officer	Aug 07 '25	Proposed Sale	320.00	1,343	429,760		Aug 07 11:35 AM
Singh Prem	SVP, Global Operations	Jun 13 '25	Option Exercise	166.62	1,257	209,441	6,470	Jun 16 04:18 PM
Singh Prem	SVP, Global Operations	Jun 13 '25	Sale	300.05	2,327	698,216	4,143	Jun 16 04:18 PM
Manea Dan	SVP, Chief HR Officer	Jun 13 '25	Sale	300.05	1,300	390,065	9,090	Jun 16 04:16 PM
Singh Prem	Officer	Jun 13 '25	Proposed Sale	300.05	2,327	698,216		Jun 13 10:15 AM
Manea Dan	Officer	Jun 13 '25	Proposed Sale	300.05	1,300	390,065		Jun 13 09:45 AM
BORIO LUCIANA	Director	Jun 09 '25	Sale	305.73	481	147,056	3,087	Jun 10 04:17 PM
BORIO LUCIANA	Director	Jun 09 '25	Proposed Sale	305.72	481	147,054		Jun 09 01:08 PM
Hollingshead James	Former Officer	May 16 '25	Proposed Sale	323.10	15,605	5,041,964		May 16 04:40 PM
Kapples John W.	SVP and General Counsel	May 14 '25	Option Exercise	95.43	5,278	503,680	28,458	May 15 04:25 PM
Kapples John W.	SVP and General Counsel	May 14 '25	Sale	318.47	5,278	1,680,885	23,180	May 15 04:25 PM
Kapples John W.	Officer	May 14 '25	Proposed Sale	318.47	5,278	1,680,901		May 14 12:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PODD

Insulet Corp

Upgrade your Finviz experience